Home >> Current Neuropharmacology, Volume 5, Number 2
Current Neuropharmacology logo Bentham Science Publishers logo

Current Neuropharmacology aims to provide current, timely and comprehensive reviews of all areas of neuropharmacology and related matters of neuroscience. The journal publishes reviews written by experts and leaders in the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Publisher: Bentham Science Publishers

Related content
Volume 5, Number 2, June 2007

< previous issue | all issues | next issue >

Articles

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration
pp. 73-80(8)
Authors: Ashton, John C.; Glass, Michelle

Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
pp. 81-97(17)
Author: Basavarajappa, Balapal S.

Parkinson's Disease: Genetics and Beyond
pp. 99-113(15)
Authors: Inamdar, N. N.; Arulmozhi, D. K.; Tandon, A.; Bodhankar, S. L.

Cell and Gene Therapies for Refractory Epilepsy
pp. 115-125(11)
Author: Boison, Detlev

Current Experimental Therapy for Alzheimer's Disease
pp. 127-134(8)
Authors: Chen, Sheng; Zhang, Xiao-Jie; Li, Liang; Le, Wei-Dong

The Neurobiological Bases for Development of Pharmacological Treatments of Aggressive Disorders
pp. 135-147(13)
Authors: Siegel, Allan; Bhatt, Suresh; Bhatt, Rekha; Zalcman, Steven S.

< previous issue | all issues | next issue >

Marked list

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page